Viquez Natasha M, Füger Petra, Valakh Vera, Daniels Richard W, Rasse Tobias M, DiAntonio Aaron
Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Neurosci. 2009 Sep 16;29(37):11484-94. doi: 10.1523/JNEUROSCI.5584-08.2009.
The synapse is composed of an active zone apposed to a postsynaptic cluster of neurotransmitter receptors. Each Drosophila neuromuscular junction comprises hundreds of such individual release sites apposed to clusters of glutamate receptors. Here, we show that protein phosphatase 2A (PP2A) is required for the development of structurally normal active zones opposite glutamate receptors. When PP2A is inhibited presynaptically, many glutamate receptor clusters are unapposed to Bruchpilot (Brp), an active zone protein required for normal transmitter release. These unapposed receptors are not due to presynaptic retraction of synaptic boutons, since other presynaptic components are still apposed to the entire postsynaptic specialization. Instead, these data suggest that Brp localization is regulated at the level of individual release sites. Live imaging of glutamate receptors demonstrates that this disruption to active zone development is accompanied by abnormal postsynaptic development, with decreased formation of glutamate receptor clusters. Remarkably, inhibition of the serine-threonine kinase GSK-3beta completely suppresses the active zone defect, as well as other synaptic morphology phenotypes associated with inhibition of PP2A. These data suggest that PP2A and GSK-3beta function antagonistically to control active zone development, providing a potential mechanism for regulating synaptic efficacy at a single release site.
突触由与神经递质受体的突触后簇相对的活性区组成。每个果蝇神经肌肉接头包含数百个这样与谷氨酸受体簇相对的单个释放位点。在这里,我们表明蛋白磷酸酶2A(PP2A)是在谷氨酸受体对面形成结构正常的活性区所必需的。当突触前抑制PP2A时,许多谷氨酸受体簇与Bruchpilot(Brp)不相对,Brp是正常递质释放所需的活性区蛋白。这些不相对的受体并非由于突触小体的突触前回缩,因为其他突触前成分仍与整个突触后特化相对。相反,这些数据表明Brp的定位在单个释放位点水平受到调控。谷氨酸受体的实时成像表明,活性区发育的这种破坏伴随着突触后发育异常,谷氨酸受体簇的形成减少。值得注意的是,抑制丝氨酸 - 苏氨酸激酶GSK - 3β完全抑制了活性区缺陷以及与抑制PP2A相关的其他突触形态表型。这些数据表明PP2A和GSK - 3β发挥拮抗作用来控制活性区发育,为在单个释放位点调节突触效能提供了一种潜在机制。